PDI Appoints Gerald P. Belle to Chairman of the Board

Monday, June 7, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

PARSIPPANY, N.J., June 7 PDI, Inc. (Nasdaq: PDII), a leading provider of promotional outsourced services to healthcare companies, today announced the appointment of Gerald P. Belle to Chairman of its Board of Directors on Thursday, June 3, replacing retiring Board Chairman John P. Dugan. Mr. Belle has been a director of the company since April of 2008 and has served as the Lead Independent Director since July of 2009.

"I am honored to have received this appointment," said Mr. Belle. "PDI is making tremendous progress, and I look forward to being part of the company's future."

"Jerry is an excellent choice for the role of Chairman for PDI," said retiring Chairman Dugan. "While I have truly enjoyed serving as Chair for the past 20 years, it is time for change, and I am delighted to be passing the board leadership to him. Jerry has the necessary expertise and skills to build upon PDI's strong growth momentum and compelling story. As PDI continues to expand its client base and service offerings, his recognized leadership will be invaluable in helping the company be strategically positioned and effectively respond to today's healthcare environment."

From 2004 until his retirement in November of 2007, Mr. Belle served as Executive Chairman of Merial Ltd., a global animal health company that was a joint venture between Sanofi-aventis and Merck & Co. Prior to that, Mr. Belle spent 35 years at Aventis, Inc., and its predecessor companies, rising to the position of President and Chief Executive Officer of North America Pharmaceuticals. Mr. Belle is Chairman of the Board of Myriad Pharmaceuticals, Inc., a publicly traded biopharmaceutical company. Mr. Belle earned a B.S.B.A. in Marketing from Xavier University in 1968 and an M.B.A. from Northwestern University in 1969.

About PDI, Inc.

PDI provides commercialization services for the healthcare industry. The company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales and marketing expertise. For more information, please visit the company's website at www.pdi-inc.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding future events and financial performance. These statements are based on current expectations and assumptions involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. These statements also involve known and unknown risks, uncertainties and other factors that may cause PDI's actual results to be materially different from those expressed or implied by any forward-looking statement. For example, with respect to statements regarding projections of future revenues, growth and profitability, actual results may differ materially from those set forth in this release based on the loss, early termination or significant reduction of any of our existing service contracts, the failure to meet performance goals in PDI's incentive-based arrangements with customers or the inability to secure additional business. Additionally, all forward-looking statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2009, and PDI's subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements. In addition, these statements speak only as of the date of this press release and, except as may be required by law, PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store